The mission of the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC) is to promote the early clinical development of promising therapies for the treatment of children, adolescents and young adults with cancer and related disorders.
Founded in February 2003, POETIC is comprised of a network of ten leading academic medical centers. Our members serve a geographically and ethnically diverse patient population, with an emphasis on comprehensive cancer care and research. POETIC is unique, our members working together to provide the collaborative and research strength needed to complete intensive phase I and II studies of novel treatment agents. By utilizing the expertise and resources of our members, POETIC offers new possibilities and hope to the field of pediatric oncology. Find out more
As we continue to expand our knowledge base of the biology of pediatric cancer, we can translate what we've learned into new therapies.
Our expertise as a group allows us to draw on our collective resources unlike any other organization.
Our organization was fostered out of the relationships POETIC Principal Investigators have with their patients and families.